PT. Penta Valent Tbk (IDX:PEVE)
Indonesia · Delayed Price · Currency is IDR 446.00
+6.00 (1.36%)
At close: Apr 28, 2026
PT. Penta Valent Tbk Revenue
In the year 2025, PT. Penta Valent Tbk had annual revenue of 3.55T IDR with 17.77% growth. PT. Penta Valent Tbk had revenue of 960.41B in the quarter ending December 31, 2025, with 17.00% growth.
Revenue
3.55T
Revenue Growth
+17.77%
P/S Ratio
0.22
Revenue / Employee
2.91B
Employees
1,218
Market Cap
787.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.55T | 535.25B | 17.77% |
| Dec 31, 2024 | 3.01T | 528.07B | 21.25% |
| Dec 31, 2023 | 2.48T | 337.34B | 15.71% |
| Dec 31, 2022 | 2.15T | 359.31B | 20.10% |
| Dec 31, 2021 | 1.79T | 407.33B | 29.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 35.32T |
| PT Siloam International Hospitals Tbk | 12.85T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.59T |
| PT Itama Ranoraya Tbk | 1.10T |
| PT Kedoya Adyaraya Tbk | 469.59B |
| PT Multi Medika Internasional Tbk | 201.47B |
| PT Diastika Biotekindo Tbk | 201.31B |